Back to Search
Start Over
Overcoming Primary Resistance to PD-1 Inhibitor With Anti-PD-L1 Agent in Squamous-Cell NSCLC: Case Report.
- Source :
-
Clinical lung cancer [Clin Lung Cancer] 2020 Mar; Vol. 21 (2), pp. e45-e48. Date of Electronic Publication: 2019 Nov 20. - Publication Year :
- 2020
- Subjects :
- Aged
Antineoplastic Agents, Immunological pharmacology
Carcinoma, Non-Small-Cell Lung immunology
Carcinoma, Non-Small-Cell Lung metabolism
Carcinoma, Non-Small-Cell Lung pathology
Female
Humans
Lung Neoplasms drug therapy
Lung Neoplasms immunology
Lung Neoplasms metabolism
Lung Neoplasms pathology
Prognosis
Antibodies, Monoclonal, Humanized therapeutic use
B7-H1 Antigen antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung drug therapy
Drug Resistance, Neoplasm drug effects
Immune Checkpoint Inhibitors therapeutic use
Nivolumab pharmacology
Programmed Cell Death 1 Receptor antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1938-0690
- Volume :
- 21
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Clinical lung cancer
- Publication Type :
- Report
- Accession number :
- 31902695
- Full Text :
- https://doi.org/10.1016/j.cllc.2019.11.011